The Drug Discovery Industry
Target prioritization is today a bottleneck as a result of the new genomics
based drug discovery. Given the exponential increase in targets provided by
the new technologies as gene expression analysis, no company can afford to
advance all of the targets identified. A target prioritization process, must
therefore be used in order to be successful, and is today a major strategic
challenge for all pharmaceutical companies. In order to establish an efficient
target prioritization process, the companies must establish a stronger link
between the protein and the disease, to get a context and better understanding
of the target functionality. InNetics is helping pharmaceutical companies
to establish this missing link, by providing in silico tools that give discovery
researchers the big picture over their target candidates and their context.
The Bioprocess Industry
The bioprocess industry is today a fast growing industry, with many different
application areas. In this industry, the goal of metabolic engineering is
to design and create optimal biocatalysts that are maximizing the productivity
of the desired products. In the efforts to design this process, they have
to elucidate the metabolic pathways and its functions in order to know how
to make for example a fermentation process more efficient. In this process,
PathwayLab is a very efficient and easy-to-use tool that provides scientists
in metabolic engineering with powerful simulation capabilities of biochemical
pathways.
